arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 3/2022 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    NEW ON THE MARKET

    Evergreening: new fumaric acid preparation for multiple sclerosis

    Vericiguat (VERQUVO): new active principle for heart failure

    mRNA-1273 (SPIKEVAX): second COVID-19 vaccine for children

    Cilgavimab plus tixagevimab (EVUSHELD) for the prevention of COVID-19 (short version)

    IN BRIEF

    AWMF downplays conflicts of interest

    Clinical studies are still published selectively
    free

    SIDE EFFECTS

    Live vaccines: infants may have severe infections after exposure to infliximab

    New meta-analysis: cancer risk with angiotensin II receptor blockers

    e a-t ON THE INTERNET

    Cilgavimab plus tixagevimab (EVUSHELD) for the prevention of COVID-19 (long version)

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles

    Wir schätzen Ihr Feedback

    Nehmen Sie an unserer Umfrage teil!